BIIB vs GILD
Biogen Inc. - Common Stock · Gilead Sciences, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | BIIB | GILD |
|---|---|---|
| Price | $209.23 | $132.73 |
| Market Cap | $30.89B | $164.79B |
| P/E | 23.89 | 19.36 |
| P/B | 1.66 | 7.01 |
| P/S | 3.12 | 5.60 |
| ROE | 6.9% | 36.2% |
| Net Margin | 13.1% | 28.9% |
| Gross Margin | 117.7% | — |
| Revenue Growth | 2.2% | 2.4% |
| Dividend Yield | — | 2.38% |
| EPS | $8.76 | $6.85 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.